American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research jointly filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of Ordinary Shares of Tecnoglass Holdings Inc. as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: The three reporting persons each reported 2,391,437 Ordinary Shares beneficially owned, representing 5.4% of the class.
  • Sole voting power: Each reporting person listed sole voting power over 2,310,957 shares, with no shared voting power reported.
  • Sole dispositive power: Each reporting person listed sole dispositive power over 2,391,437 shares, with no shared dispositive power reported.
  • Triggering date: The event requiring this filing occurred on September 30, 2026.
  • Corporate structure: According to the filing, American Century Investment Management, Inc. is a wholly-owned subsidiary of American Century Companies, Inc., which is controlled by Stowers Institute for Medical Research.
  • Ordinary course certification: The filing states the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

American Century Entities Report Joint 5.4% Position in Tecnoglass Ordinary Shares

According to the Schedule 13G filed November 16, 2026, three affiliated entities - American Century Investment Management, Inc. (ACIM), American Century Companies, Inc. (ACC), and Stowers Institute for Medical Research - jointly disclosed beneficial ownership of 2,391,437 Ordinary Shares of Tecnoglass Holdings Inc. The filing identifies the issuer's principal executive offices as 3550 NW 49th Street, Miami, Florida, 33142. The filing does not identify an exchange or ticker symbol in its text.

The filing describes ACIM as an investment adviser registered under Section 203 of the Investment Advisers Act of 1940 and a wholly-owned subsidiary of ACC. Stowers Institute for Medical Research is identified as the control entity of ACC. The filing notes that "various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule." The filing further states that no single client advised by ACIM owns more than 5% of the class.

The joint filing was signed on November 16, 2026, by John Pak, Senior Vice President, on behalf of ACIM and ACC, and by Joselyn Verschelden as Authorized Signer on behalf of Stowers Institute for Medical Research. The filing was submitted pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, with the reporting persons certifying the holdings are maintained in the ordinary course of business.

What Was Disclosed

Three affiliated entities jointly reported beneficial ownership of 2,391,437 Ordinary Shares of Tecnoglass Holdings Inc., equal to 5.4% of the class, with sole voting power over 2,310,957 shares, as of September 30, 2026.